whether to treat ALL patients with type 2 diabetes with an ACE inhibitor to prevent nephropathy

January 2000

Experts are debating whether to treat ALL patients with type 2 diabetes with an ACE inhibitor to prevent nephropathy.

The current recommendation is to screen patients annually...then treat only patients who develop microalbuminuria.

But some experts advocate earlier treatment...to prevent nephropathy before it occurs. Treating all type 2s is more effective...but costs more than the traditional approach.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote